IDEXX Laboratories (IDXX) vs. ZTS and NEOG: Can Raised Guidance and Product Expansion Drive Further Earnings Growth?

insidermonkey.com · 2026-10-22

Is IDXX a good stock to buy? We came across a bullish thesis on IDEXX Laboratories, Inc. on Astute Optics - US’s Substack. In this article, we will summarize the bulls’ thesis on IDXX.

TickrTrends take: IDEXX Laboratories operates in the Healthcare sector where TickrTrends currently identifies the stock as undervalued, suggesting potential upside if the company can sustain earnings momentum. The raised guidance and product expansion mentioned in recent analysis indicate management confidence in revenue and profit growth, which would support closing any valuation gap if execution continues as projected. Investors focused on valuation should monitor whether IDEXX's earnings growth rate can accelerate enough to justify current market positioning relative to comparable companies like Zoetis and Neogen.

Read the full story at insidermonkey.com →